Targeting human coatomer subunit zeta-1 by a marine natural product derivative represents a new therapeutic strategy to inhibit enterovirus A71 replication
This study is spearheaded by researcher Wu Zhong (National Engineering Research Center for the Emergence Drugs, Beijing Institute of Pharmacology and Toxicology, Beijing) and Prof. Yong Qin (West China School of Pharmacy, Sichuan University). In a recent effort to identify the anti-EV-A71 target of a marine